Probiotic-based anticancer therapy: Probiotic Lactobacillus Rhamnosus increases the expression of mitochondrial protein LACTB, decreases levels of mitochondrial phosphatidylserine decarboxylase, alters mitochondrial lipid metabolism, and promotes differentiation of breast cancer cells, via up-regulation of its target gene, 12/November/2017, 7.41 pm

A probiotic way to stay free of blood sugar disease (autoimmune diabetes): Probiotic Clostridium Butyricum increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 7/november/2018, 11.40 pm
November 7, 2018
Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced ovarian cancer and other metastatic cancers: A pharmaceutical mixture encompassing Olaparib, an FDA-approved poly (adenosine diphosphate-ribose) polymerase inhibitor, and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as FOXO1, CADM2,  p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets ovarian cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 12/November/2018, 8.01 pm
November 12, 2018
Show all

Introduction: What they say:

A study from the Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts, USA, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; and MIT Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA shows that “LACTB is a tumor suppressor that modulates lipid metabolism and cell state” This study was published, in the 22 March 2017 issue of the journalNature” [One of the best journals in General Science with an I.F of 43 plus], by Prof. Robert A Weinberg, Zuzana Keckesova, and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Probiotic-based anticancer therapy: Probiotic Lactobacillus Rhamnosus increases the expression of mitochondrial protein LACTB, decreases levels of mitochondrial phosphatidylserine decarboxylase, alters mitochondrial lipid metabolism, and promotes differentiation of breast cancer cells via up-regulation of its target gene

Price 300

[easy_payment currency=”USD”]


From Significance of the study to Public health relevance:

Given that: (i) each year nearly 14 million people are diagnosed with cancer globally; (ii) cancer deaths globally are expected to be doubled in a little more than decades time; (iii) cancer treatment causes the highest economic loss compared to all the known causes of death worldwide; (iv) Breast cancer not only the most common women cancer, but also the most common invasive cancer in women; (v) Breast cancer not only metastasizes frequently, but also relapses; (vi) in 2008, breast cancer has caused more than 400000 deaths; and it is the second leading cause of cancer death in women; (vii) in 2008, breast cancer has caused economic loss of 88 billion US dollars worldwide; (viii) cancer causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) a way to activate cancer patients immune system against tumors (Cancer immunotherapy); (ii) a cheaper alternative to the existing expensive anticancer drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to effectively treat and prevent metastatic progression and relapse of cancers.


What we infer from what they say:

Prof. Bob Weinberg’s research team has recently shown that mitochondrial protein LACTB: (1) inhibits proliferation of breast cancer cells; (2) alters mitochondrial lipid metabolism; (3) decreases the levels of mitochondrial phosphatidylserine decarboxylase (required for the synthesis of mitochondrial phosphatidylethanolamine); (4) promotes differentiation of breast cancer cells, suggesting that induction of LACTB in breast cancer cells may inhibit its proliferation.


From research findings to therapeutic opportunity :

This study suggests a probiotic-based therapy for human cancers.  Probiotic Lactobacillus Rhamnosus, by increasing the expression of its target genes, it may increase the expression of LACTB (fig. 1). Thereby, it may: (i) stall proliferation of breast cancer cells; (ii) alter mitochondrial lipid metabolism; (iii) decrease mitochondrial phosphatidylserine decarboxylase levels; (iv) decrease mitochondrial phosphatidylethanolamine levels; and (v) promote differentiation of breast cancer cells (fig.1).

Figure 1. Mechanistic insights into how Probiotic Lactobacillus Rhamnosus increases the expression of tumor suppressor LACTB and promote differentiation of tumor cells

Figure 2. Probiotic Lactobacillus Rhamnosus functions as an anti-cancer agent.

Thus, pharmacological formulations encompassing “Probiotic Lactobacillus Rhamnosus, either alone or in combination with other known anticancer drugs or probiotics,” may be used to inhibit tumor proliferation and promote tumor differentiation.


Details of the Research findings:

Idea Proposed/Formulated (with experimental evidence) by Dr L Boominathan Ph.D.

Amount: $300#

Undisclosed mechanistic information: How does Probiotic Lactobacillus Rhamnosus increase the expression of LACTB ?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

For purchase and payment details, you may reach us at info@genomediscovery.org

#Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L., Probiotic-based anticancer therapy: Probiotic Lactobacillus Rhamnosus increases the expression of mitochondrial protein LACTB, decreases levels of mitochondrial phosphatidylserine decarboxylase, alters mitochondrial lipid metabolism, and promotes differentiation of breast cancer cells via up-regulation of its target gene, 12/November/2017, 7.40 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, Kindly drop us a line at admin@genomediscovery.org

Comments are closed.